- Report
- October 2024
- 349 Pages
Global
From €3686EUR$4,200USD£3,189GBP
- Report
- February 2025
- 185 Pages
Global
From €3357EUR$3,825USD£2,905GBP
€3949EUR$4,500USD£3,417GBP
- Report
- July 2024
- 185 Pages
Global
From €3357EUR$3,825USD£2,905GBP
€3949EUR$4,500USD£3,417GBP
- Report
- July 2024
- 100 Pages
Global
From €4169EUR$4,750USD£3,607GBP
- Report
- June 2025
- 400 Pages
Global
From €4343EUR$4,949USD£3,758GBP
- Report
- April 2025
- 180 Pages
Global
From €3949EUR$4,500USD£3,417GBP
- Report
- May 2023
- 119 Pages
Global
From €3949EUR$4,500USD£3,417GBP
- Report
- November 2022
- 138 Pages
Global
From €1755EUR$2,000USD£1,519GBP
The Biomedical R&D market is a subset of the biotechnology industry that focuses on the development of medical products and services. It includes research and development of drugs, medical devices, diagnostics, and other healthcare products. Companies in this market typically conduct research and development activities to create new products and services, as well as to improve existing ones. They also work to develop new technologies and processes to improve the efficiency and effectiveness of healthcare delivery.
The Biomedical R&D market is highly competitive, with many companies competing for market share. Companies in this market must be able to develop innovative products and services that meet the needs of healthcare providers and patients. They must also be able to effectively market their products and services to potential customers.
Some of the major companies in the Biomedical R&D market include Johnson & Johnson, Merck & Co., Pfizer, Novartis, and Roche. Other companies in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, and Sanofi. Show Less Read more